TERRAMYCIN INHIBITION OF GLUCONATE OXIDATION BY ESCHERICHIA COLI

Por Kraskin, K. S., Stern, A. M.
Publicado em 1957

All quiet on the third coast: medical inspections of immigrants in Michigan.

Por Stern, A M, Markel, H
Publicado em 1999

UTILIZATION OF FATTY ACIDS BY AND LIPOLYTIC ACTIVITIES OF MUCOR MUCEDO

Por Stern, A. M., Ordal, Z. John, Halvorson, H. O.
Publicado em 1954

Holt-Oram syndrome: clinical and genetic study of a large family.

Por Gall, J C, Stern, A M, Cohen, M M, Adams, M S, Davidson, R T
Publicado em 1966

Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma.

Por Lavaissiere, L, Jia, S, Nishiyama, M, de la Monte, S, Stern, A M, Wands, J R, Friedman, P A
Publicado em 1996

Oto-palato-digital syndrome: comparison of clinical and radiographic manifestations in males and females.

Por Gall, J C, Stern, A M, Poznanski, A K, Garn, S M, Weinstein, E D, Hayward, J R
Publicado em 1972

Occurrence of beta-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domains.

Por Przysiecki, C T, Staggers, J E, Ramjit, H G, Musson, D G, Stern, A M, Bennett, C D, Friedman, P A
Publicado em 1987

Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX.

Por Gronke, R S, VanDusen, W J, Garsky, V M, Jacobs, J W, Sardana, M K, Stern, A M, Friedman, P A
Publicado em 1989

A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-s...

Por Jia, S, McGinnis, K, VanDusen, W J, Burke, C J, Kuo, A, Griffin, P R, Sardana, M K, Elliston, K O, Stern, A M, Friedman, P A
Publicado em 1994